Murray H W, Squires K E, Miralles C D, Stoeckle M Y, Granger A M, Granelli-Piperno A, Bogdan C
Division of Infectious Diseases, Cornell University Medical College, New York, NY 10021.
J Immunol. 1992 Mar 15;148(6):1858-63.
In naive BALB/c mice, acquisition of resistance to Leishmania donovani and formation of antileishmanial tissue granulomas are linked expressions that require both L3T4+ and Lyt 2+ cells as well as both IL-2 and IFN-gamma. To determine the mechanisms of established resistance to L. donovani, rechallenged immune BALB/c mice were treated with T cell- and lymphokine-depleting mAb or cyclosporin A. In the liver, resistance to rechallenge was inhibited by treatment with anti-Lyt 2 but not anti-L3T4 mAb. Resistance was also impaired by anti-IL-2 treatment but not by anti-IFN-gamma mAb. The hepatic granulomatous response to rechallenge, however, was not impaired by either anti-Lyt 2 or anti-IL-2 mAb nor by anti-L3T4 or anti-IFN-gamma treatment. In contrast, cyclosporin A suppressed granuloma formation but not antileishmanial activity. These results indicate a particularly important antileishmanial host defense role for Lyt 2+ cells and IL-2 in sensitized animals, and when compared to prior observations in L. donovani-infected naive mice, suggest that 1) discrete T cell- and lymphokine-dependent mechanisms are involved in initial acquisition of resistance vs established immunity, 2) more than one mechanism can mediate the development of tissue granulomas, and 3) granuloma formation by itself may not be required nor necessarily sufficient to confer antimicrobial activity.
在未接触过抗原的BALB/c小鼠中,获得对杜氏利什曼原虫的抗性以及形成抗利什曼原虫组织肉芽肿是相关的表现,这需要L3T4+和Lyt 2+细胞以及IL-2和IFN-γ。为了确定对杜氏利什曼原虫已建立抗性的机制,用耗竭T细胞和淋巴因子的单克隆抗体或环孢菌素A处理再次受到攻击的免疫BALB/c小鼠。在肝脏中,用抗Lyt 2单克隆抗体处理可抑制对再次攻击的抗性,而抗L3T4单克隆抗体则不能。抗IL-2处理也会损害抗性,但抗IFN-γ单克隆抗体则不会。然而,对再次攻击的肝脏肉芽肿反应,无论是抗Lyt 2还是抗IL-2单克隆抗体,以及抗L3T4或抗IFN-γ处理均未损害。相比之下,环孢菌素A抑制肉芽肿形成,但不抑制抗利什曼原虫活性。这些结果表明,在致敏动物中,Lyt 2+细胞和IL-2在抗利什曼原虫宿主防御中具有特别重要的作用,并且与先前在感染杜氏利什曼原虫的未接触过抗原的小鼠中的观察结果相比表明:1)在初始获得抗性与已建立的免疫中涉及不同的T细胞和淋巴因子依赖性机制;2)不止一种机制可介导组织肉芽肿的发展;3)肉芽肿形成本身可能并非赋予抗菌活性所必需,也不一定足够。